Osteoporosis, bone & mineral

Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05

Osteoporos IntPublished Randomised controlled trial

Primary result · Morphometric vertebral fractureResult — go to the resultRate ratio 0.69 95% CI 0.54–0.88

Authors' conclusion

Once-weekly injection of teriparatide, followed by alendronate resulted in a significantly lower incidence of morphometric vertebral fracture than alendronate monotherapy in women with osteoporosis who were at high risk of fracture.

Study context

Population
Japanese women aged at least 75 years with primary osteoporosis at high risk of fracture489 and 496 in main analysis
Participants
505 vs 506
Comparison
Once-weekly SC teriparatide 56.5 μg for 72 weeks, then alendronate for 48 weeks, vs alendronate monotherapy for 120 weeks
  • Sequential therapyn = 505
  • Monotherapyn = 506reference
Primary endpoint
Incidence of morphometric vertebral fracture
Follow-up
120 weeks
Methodological detailsprospective, open-label, blinded-endpoint, Enrolment October 2014 to June 2020
  • Prospective
  • Open-label
  • Blinded-endpoint
  • Enrolment October 2014 to June 2020

Primary result

Morphometric vertebral fracture

Rate ratio

0.69

95% CI 0.54–0.88

P < 0.01

Events by treatment group

Sequential therapy

0.1020

64 of 505

Monotherapy

0.1492

126 of 506

Sequential therapyvs Monotherapy
rate ratio 0.69 (95% CI 0.54–0.88); P < 0.01

As reported in the abstract

Safety

Severe adverse events considered related to study drug · after 72 weeks

No patient had a severe drug-related adverse event

Original publication

Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05. Osteoporos Int. Published 14 October 2022. doi:10.1007/s00198-022-06570-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.